A Gas Therapy Strategy for Intestinal Flora Regulation and Colitis Treatment by Nanogel‐Based Multistage NO Delivery Microcapsules
Advanced Materials · 2024
DOI: 10.1002/adma.202309972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Ya-Jun Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Polymer Science and Engineering, Sichuan University, Chengdu, 610065, China. Hauptthemen laut MEDLINE: Colitis, Capsules, Gastrointestinal Microbiome, Nanogels. Die Arbeit wurde bisher 105-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province, Med-X Innovation Programme of Med-X Center for Materials of Sichuan University.
Abstract (Originalsprache)
Current approaches to treating inflammatory bowel disease focus on the suppression of overactive immune responses, the removal of reactive intestinal oxygen species, and regulation of the intestinal flora. However, owing to the complex structure of the gastrointestinal tract and the influence of mucus, current small‐molecule and biologic‐based drugs for treating colitis cannot effectively act at the site of colon inflammation, and as a result, they tend to exhibit low efficacies and toxic side effects. In this study, nanogel‐based multistage NO delivery microcapsules are developed to achieve NO release at the inflammation site by targeting the inflammatory tissues using the nanogel. Surprisingly, oral administration of the microcapsules suppresses the growth of pathogenic bacteria and increases the abundance of probiotic bacteria. Metabolomics further show that an increased abundance of intestinal probiotics promotes the production of metabolites, including short‐chain fatty acids and indole derivatives, which modulate the intestinal immunity and restore the intestinal barrier via the interleukin‐17 and PI3K‐Akt signaling pathways. This work reveals that the developed gas therapy strategy based on multistage NO delivery microcapsules modulates the intestinal microbial balance, thereby reducing inflammation and promoting intestinal barrier repair, ultimately providing a new therapeutic approach for the clinical management of colitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Polymer Science and Engineering, Sichuan University, Chengdu, 610065, China.
- Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, 610041, China.
- Division of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, 610032, China.
ORCID-Profile: Wei Yang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
- Med-X Innovation Programme of Med-X Center for Materials of Sichuan University
- Sichuan University Postdoctoral Interdisciplinary Innovation Fund
Zitieren
APA
Fu, Y. J., Zhao, X., Wang, L. Y., Li, K., Jiang, N., Zhang, S. T., Wang, R. K., Zhao, Y. F., & Yang, W. (2024). A Gas Therapy Strategy for Intestinal Flora Regulation and Colitis Treatment by Nanogel‐Based Multistage NO Delivery Microcapsules. Advanced Materials. https://doi.org/10.1002/adma.202309972
Vancouver
Fu YJ, Zhao X, Wang LY, Li K, Jiang N, Zhang ST, et al. A Gas Therapy Strategy for Intestinal Flora Regulation and Colitis Treatment by Nanogel‐Based Multistage NO Delivery Microcapsules. Advanced Materials. 2024. doi:10.1002/adma.202309972
BibTeX
@article{Fu2024,
author = {Fu, Ya-Jun and Zhao, Xing and Wang, Li-Ya and Li, Kai and Jiang, Niu and Zhang, Shu-Ting and Wang, Rao-Kaijuan and Zhao, Yi-Fan and Yang, Wei},
title = {A Gas Therapy Strategy for Intestinal Flora Regulation and Colitis Treatment by Nanogel‐Based Multistage NO Delivery Microcapsules},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202309972}
}
EUVIMED